SCHEMBL24945665

SCHEMBL24945665

CCOc1cnc(N2CCN(C(=O)OC3CC4(C3)CN(Cc3ccccc3)C4)CC2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.45
PKM P14618 1/20 0.45
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 4/20 0.42
CYP3A4 P08684 3/20 0.42
USP2 O75604 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
KMT2A Q03164 1/20 0.41
CYP2D6 P10635 3/20 0.41
HTR7 P34969 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
GHSR Q92847 1/20 0.41
FAAH O00519 2/20 0.41
TSHR P16473 1/20 0.41
CHRM2 P08172 2/20 0.40
CHRM1 P11229 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24945637 0.90 CYP3A4 (0.41) MAPK1KDM4EALDH1A1CYP3A4USP2
SCHEMBL23744120 0.90 CYP2D6 (0.45) MAPK1ALDH1A1CYP3A4USP2CYP1A2
SCHEMBL24945761 0.89 HTR7 (0.44) MAPK1ALDH1A1CYP3A4USP2CYP1A2
SCHEMBL23744809 0.88 CYP2D6 (0.42) MAPK1ALDH1A1CYP3A4USP2CYP1A2
SCHEMBL23744790 0.88 CHRM2 (0.41) ALDH1A1CYP3A4USP2CYP1A2CYP2C9
SCHEMBL24944794 0.88 ALDH1A1 (0.40) MAPK1SMN1; SMN2ALDH1A1CYP3A4USP2
SCHEMBL31492292 0.86 CHRM2 (0.44) MAPK1PKMCHRM2CHRM1CHRM3
SCHEMBL26089375 0.85 CYP3A4 (0.46) SMN1; SMN2ALDH1A1CYP3A4USP2CYP1A2
SCHEMBL26087084 0.85 CHRM2 (0.56) CYP3A4USP2CYP1A2CYP2D6HTR7
SCHEMBL24944734 0.83 CYP3A4 (0.40) MAPK1LMNAALDH1A1CYP3A4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010078-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2023-02-02 WO disclosed